Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Emily Lai-Ho MacLean

Biographic Data

ID9066812
NAMEEmily Lai-Ho MacLean
GIVEN NAMESEmily Lai-Ho
FAMILY NAMEMacLean
SIGNATUREMACLEAN E L
AFFILIATIONSMcGill University Health Centre
ORCID0000-0001-9272-0985
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Fighting tuberculosis hand in hand

    Open Access•Nandini Venkatesan, Lena Faust et al.•ARTICLE•PLOS Global Public Health•2025

    Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We ackn…

  • Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Open Access•Emily Lai-Ho MacLean, Paolo Miotto et al.•ARTICLE•PLOS Global Public Health•2023

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deployable in peripheral settings. In 2014, World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal cri…

  • Most common reasons for primary care visits in low- and middle-income countries

    Open Access•Jacob Bigio, Emily Lai-Ho MacLean et al.•ARTICLE•PLOS Global Public Health•2022

    With the Covid-19 pandemic and the introduction of the WHO’s Essential Diagnostics List (EDL), increasing global attention is focused on the crucial role of diagnostics in achieving universal health coverage. To create national EDLs and to aid health system planning, it is vital to understand the most common conditions with which people present at primary care health facilities. We undertook a systematic review of the most common reasons for prim…

  • You Only Die Twice

    Jean-Paul R Soucy, Jean‐Paul Soucy et al.•ARTICLE•American Journal of Public Health•2019•References: 1

    AffiliationsJean-Paul R. Soucy, Stephen A. Kutcher, and Emily MacLean are with the Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. Maida J. Sewitch is with the Department of Medicine, McGill University, and the Research Institute of the McGill University Health Centre, Montreal, Quebec

No prominent works on this page.

  • You Only Die Twice

    Jean-Paul R Soucy, Jean‐Paul Soucy et al.•ARTICLE•American Journal of Public Health•2019•References: 1

    AffiliationsJean-Paul R. Soucy, Stephen A. Kutcher, and Emily MacLean are with the Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. Maida J. Sewitch is with the Department of Medicine, McGill University, and the Research Institute of the McGill University Health Centre, Montreal, Quebec

  • Most common reasons for primary care visits in low- and middle-income countries

    Open Access•Jacob Bigio, Emily Lai-Ho MacLean et al.•ARTICLE•PLOS Global Public Health•2022

    With the Covid-19 pandemic and the introduction of the WHO’s Essential Diagnostics List (EDL), increasing global attention is focused on the crucial role of diagnostics in achieving universal health coverage. To create national EDLs and to aid health system planning, it is vital to understand the most common conditions with which people present at primary care health facilities. We undertook a systematic review of the most common reasons for prim…

  • Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

    Open Access•Emily Lai-Ho MacLean, Paolo Miotto et al.•ARTICLE•PLOS Global Public Health•2023

    There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deployable in peripheral settings. In 2014, World Health Organization (WHO) published target product profiles (TPPs) which detailed minimal and optimal cri…

  • Fighting tuberculosis hand in hand

    Open Access•Nandini Venkatesan, Lena Faust et al.•ARTICLE•PLOS Global Public Health•2025

    Tuberculosis (TB) is an infectious disease closely intertwined with stigma, discrimination, and the social determinants of health. Communities of people affected by TB are experts in their care pathways, but the TB field continues to fall short of meaningfully engaging communities in TB research. This is a missed opportunity to improve the quality, relevance, person-centeredness, positive impact, and sustainability of TB research outputs. We ackn…

Medicine (3 works) · Mycobacterium research and diagnosis (2 works) · Pathology (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works) · Biology (1 work) · Biostatistics (1 work) · Business (1 work) · Community engagement (1 work) · Drug (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae